Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 205

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

Khawaja, Xavier, Xu, Jun, Liang, Jin‐Jun, Barrett, James E.·2004·Journal of Neuroscience Research

Abstract

It is recognized that monoamine reuptake inhibitors (MARIs) exert beneficial effects in the treatment of major depression and general anxiety disorder. The aim of this study was to identify proteins regulated by this class of antidepressant using a proteome differential profiling approach. Either venlafaxine or fluoxetine was administered systemically to adult rats for 2 weeks, and protein patterns from rat hippocampal cytosolic extracts were compared by two‐dimensional gel electrophoresis. Silver‐stained protein spots displaying differential expression were identified by mass spectrometry. Thirty‐three protein spots were modulated by both drug treatments compared to controls. The classification of several proteins that were sorted by function suggested convergent pathway activities for both MARIs at the post‐receptor level. These included proteins associated with neurogenesis (insulin like growth factor 1 (IGF‐1), glia maturation factor [GMF]‐β), outgrowth/maintenance of neuronal processes (hippocampal cholinergic neurostimulating peptide [HCNP], PCTAIRE‐3), and with neural regeneration/axonal guidance collapsin response mediator protein (CRMP‐2) systems. Other modulated proteins indicated an increase in neuronal vesicular cell trafficking and synaptic plasticity (Ras‐related protein 4a (Rab4a), Ras‐related protein 1b (Rab1b), heat shock protein 10 [HSP10]), as well as neurosteroidogenic (hydroxysteroid sulfotransferase A) and possible anti‐apoptotic (dimethylargininase‐1 L‐N,N‐dimethylarginine dimethylaminohydrolase‐1 [DDAH‐1], pyruvate dehydrogenase‐E1 [PDH‐E1], antioxidant protein‐2 [AOP‐2]) pathway‐mediated regulatory events. Parallel studies to investigate further the effects of venlafaxine and fluoxetine on adult hippocampal neurogenesis in vivo by quantitative bromodeoxyuridine immunolabeling revealed a significant drug‐induced increase in the proliferation rate and long‐term survivability of progenitor stem cells located in the subgranular zone. These data suggest that MARIs share wide‐ranging proteome changes within the hippocampal formation, beyond 5‐HT/NE neurotransmission. This may reflect long‐term functional adaptations required for antidepressant activity. © 2004 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jnr.10869

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 205

Metadata

Authors
Khawaja, X., Xu, J., Liang, J., & Barrett, J. E.
Venue
Journal of Neuroscience Research
Publisher
Wiley
Published
2004-01-20
Volume
75
Issue
4
Pages
451-460
ISSN
  • 0360-4012 (ISSN-L)
  • 1097-4547
OpenAlex
W2164698340
Cited by
205
References
4
FWCI
9.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. https://app.cochat.ai/papers/10.1002/jnr.10869
The paper
Khawaja, X., Xu, J., Liang, J., & Barrett, J. E. (2004). Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.10869

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.